NATURAL ALTERNATIVES INTERNATIONAL INC
For the period ended Mar 31, 2026. Filed May 19, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 19, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)
Condensed Consolidated Statements of Stockholders’ Equity
Three-Month Periods Ended March 31, 2026 and 2025
(Dollars in thousands)
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Paid-in · Retained · Treasury Stock · Comprehensive | ||||||||
| Shares | Amount | Capital | Earnings | Shares | Amount | (Loss) Income | Total | |
| Balance, December 31, 2025 | 9,504,906 | $93 | $33,966 | $56,547 | 3,328,128 | $(23,259) | $(301) | $67,046 |
| Compensation expense related to stock compensation plans | — | — | 140 | — | — | — | — | 140 |
| Issuance of common stock for restricted stock grants | 139,000 | 1 | — | — | — | — | — | 1 |
| Repurchase of common stock | — | — | — | — | 29,884 | (82) | — | (82) |
| Forfeiture of restricted stock | — | — | — | — | 10,665 | — | — | — |
| Unrealized gain resulting from change in fair value of derivative instruments, net of tax | — | — | — | — | — | — | 316 | 316 |
| Net loss | — | — | — | (4,311) | — | — | — | (4,311) |
| Balance, March 31, 2026 | 9,643,906 | $94 | $34,106 | $52,236 | 3,368,677 | $(23,341) | $15 | $63,110 |
| Balance, December 31, 2024 | 9,480,906 | $93 | $33,187 | $68,793 | 3,282,128 | $(23,084) | $152 | $79,141 |
| Compensation expense related to stock compensation plans | — | — | 245 | — | — | — | — | 245 |
| Issuance of common stock for restricted stock grants | 24,000 | — | — | — | — | — | — | — |
| Change in minimum pension liability, net of tax | — | — | — | — | — | — | 1 | 1 |
| Repurchase of common stock | — | — | — | — | 43,880 | (168) | — | (168) |
| Unrealized loss resulting from change in fair value of derivative instruments, net of tax | — | — | — | — | — | — | (414) | (414) |
| Net loss | — | — | — | (2,186) | — | — | — | (2,186) |
| Balance, March 31, 2025 | 9,504,906 | $93 | $33,432 | $66,607 | 3,326,008 | $(23,252) | $(261) | $76,619 |
Natural Alternatives International, Inc.
Condensed Consolidated Statements of Stockholders’ Equity
Nine-Month Periods Ended March 31, 2026 and 2025
(Dollars in thousands)
| Accumulated | ||||||||
|---|---|---|---|---|---|---|---|---|
| Additional · Other | ||||||||
| Common Stock · Paid-in · Retained · Treasury Stock · Comprehensive | ||||||||
| Shares | Amount | Capital | Earnings | Shares | Amount | (Loss) Income | Total | |
| Balance, June 30, 2025 | 9,504,906 | $93 | $33,611 | $59,391 | 3,326,693 | $(23,254) | $(1,415) | $68,426 |
| Compensation expense related to stock compensation plans | — | — | 495 | — | — | — | — | 495 |
| Issuance of common stock for restricted stock grants | 139,000 | 1 | — | — | — | — | — | 1 |
| Repurchase of common stock | — | — | — | — | 31,319 | (87) | — | (87) |
| Forfeiture of restricted stock | — | — | — | — | 10,665 | — | — | — |
| Unrealized gain resulting from change in fair value of derivative instruments, net of tax | — | — | — | — | — | — | 1,430 | 1,430 |
| Net loss | — | — | — | (7,155) | — | — | — | (7,155) |
| Balance, March 31, 2026 | 9,643,906 | $94 | $34,106 | $52,236 | 3,368,677 | $(23,341) | $15 | $63,110 |
| Balance, June 30, 2024 | 9,480,906 | $93 | $32,634 | $72,966 | 3,280,721 | $(23,076) | $(22) | $82,595 |
| Compensation expense related to stock compensation plans | — | — | 798 | — | — | — | — | 798 |
| Issuance of common stock for restricted stock grants | 24,000 | — | — | — | — | — | — | — |
| Change in minimum pension liability, net of tax | — | — | — | — | — | — | (7) | (7) |
| Repurchase of common stock | — | — | — | — | 45,287 | (176) | — | (176) |
| Unrealized loss resulting from change in fair value of derivative instruments, net of tax | — | — | — | — | — | — | (232) | (232) |
| Net loss | — | — | — | (6,359) | — | — | — | (6,359) |
| Balance, March 31, 2025 | 9,504,906 | $93 | $33,432 | $66,607 | 3,326,008 | $(23,252) | $(261) | $76,619 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.